Hyperfine (HYPR) Research & Development (2021 - 2026)
Hyperfine (HYPR) reported Research & Development of $3.8 million for Q1 2026, down 23.66% on a YoY basis from $5.0 million in Q1 2025, and up 0.52% quarter-over-quarter from $3.8 million in Q4 2025.
Hyperfine (HYPR) Research & Development (2021 - 2026) Analysis & Trends
Hyperfine has reported Research & Development for 6 years, with the latest figure at $3.8 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 23.66% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $16.3 million (down 25.98% YoY), and the FY2025 full-year result was $17.5 million, down 22.44% from the prior year.
- Research & Development for Q1 2026 stood at $3.8 million, up from $3.8 million in the prior quarter.
- The five-year high for Research & Development was $8.3 million in Q1 2022, with the low at $3.8 million in Q4 2025.
- Historically, Research & Development has averaged $5.6 million across 5 years, with a median of $5.5 million in 2023.
- The largest YoY upside for Research & Development was 86.28% in 2022 against a maximum downside of 41.31% in 2022.
- Hyperfine's Research & Development stood at $5.2 million in 2022, then increased by 14.24% to $6.0 million in 2023, then decreased by 14.37% to $5.1 million in 2024, then fell by 25.07% to $3.8 million in 2025, then climbed by 0.52% to $3.8 million in 2026.
- The last three Research & Development figures came in at $3.8 million (Q1 2026), $3.8 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | 3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.85 Mn |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.57 Mn |
| Dec 31, 2023 | 5.96 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 5.46 Mn |
| Dec 31, 2022 | 5.22 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.27 Mn |
| Mar 31, 2022 | 8.33 Mn |
| Dec 31, 2021 | 8.89 Mn |
| Sep 30, 2021 | 6.44 Mn |
| Jun 30, 2021 | 6.04 Mn |